Short answer · Medically reviewed summary · Last updated: 2026-05-08
Adenoid Cystic Carcinoma (ACC) is a rare, malignant tumor of the secretory glands, most commonly originating in the head and neck. While it is officially recognized as Adenoid Cystic Carcinoma, it has historically been referred to as cylindroma, a term now considered obsolete due to its potential for confusion with benign skin conditions. What are the historical and alternative names for Adenoid Cystic Carcinoma? In older medical literature, you may encounter the term cylindroma, which was used to describe the microscopic "cylindrical" patterns of the tumor cells.
Adenoid Cystic Carcinoma (ACC) is a rare, malignant tumor of the secretory glands, most commonly originating in the head and neck. While it is officially recognized as Adenoid Cystic Carcinoma, it has historically been referred to as cylindroma, a term now considered obsolete due to its potential for confusion with benign skin conditions.
In older medical literature, you may encounter the term cylindroma, which was used to describe the microscopic "cylindrical" patterns of the tumor cells. However, modern medical terminology has largely moved away from this because "cylindroma" is also the name of a distinct, benign skin appendage tumor. Using the term Adenoid Cystic Carcinoma is essential to avoid misdiagnosis and ensure clarity in your medical records.
Major medical databases and classification systems have standardized the nomenclature to ensure consistency for patients and researchers worldwide. Understanding these codes can help you navigate your diagnostic reports:
The evolution of the name Adenoid Cystic Carcinoma reflects the history of pathology. Early pathologists named tumors based solely on visual patterns observed under a microscope. As our understanding of the molecular basis of Adenoid Cystic Carcinoma has improved, the medical community has shifted toward names that reflect the tumor's biological behavior rather than just its shape. Today, Adenoid Cystic Carcinoma is the universally preferred term in clinical trials, oncology reports, and international research.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with your healthcare team for diagnosis and treatment.